Successful commercialization of promising emerging technology requires risk mitigation in the development the commercialization strategy. A Strategy Inc. Risk Analysis identifies the specific strengths, weaknesses, opportunities and threats (SWOT) for a technology under development to ensure a comprehensive overview for informed decision-making.
The Risk Analysis encompasses all areas of lifescience innovation development, including:
- Market acceptance
This comprehensive Risk Analysis guides executive planning for prioritization of resources as the development process and commercialization plans are formalized.